Published in Can J Cardiol on March 01, 2010
Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary. Can J Cardiol (2010) 1.07
Atrial septal defects - clinical manifestations, echo assessment, and intervention. Clin Med Insights Cardiol (2015) 0.87
Building quality indicators to improve care for adults with congenital heart disease. J Am Coll Cardiol (2013) 0.85
Tailored circulatory intervention in adults with pulmonary hypertension due to congenital heart disease. Neth Heart J (2016) 0.83
Emerging Research Directions in Adult Congenital Heart Disease: A Report From an NHLBI/ACHA Working Group. J Am Coll Cardiol (2016) 0.81
Constrictive pericarditis-induced shunting through a PFO: Persistence despite pericardiectomy. Respir Med Case Rep (2017) 0.75
Simple congenital heart disease: a complex challenge for public health. J Thorac Dis (2016) 0.75
The importance of copy number variation in congenital heart disease. NPJ Genom Med (2016) 0.75
Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol (2002) 6.01
Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol (2002) 5.41
A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med (1995) 4.99
Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet (1997) 4.92
Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med (1990) 4.70
Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation (2001) 3.89
Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation (2006) 3.05
Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol (1998) 2.90
In-hospital mortality for surgical repair of congenital heart defects: preliminary observations of variation by hospital caseload. Pediatrics (1995) 2.60
Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years. Eur Heart J (2003) 2.49
Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J (1998) 2.44
Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure. Heart (2007) 2.30
Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med (1999) 2.26
Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study. Circulation (2006) 2.23
Surgical treatment for secundum atrial septal defects in patients >40 years old. A randomized clinical trial. J Am Coll Cardiol (2001) 2.21
NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol (2003) 2.09
Preoperative transcatheter closure of congenital muscular ventricular septal defects. N Engl J Med (1991) 2.00
Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J Thorac Cardiovasc Surg (1999) 1.97
Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J (2009) 1.93
Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart (2003) 1.86
Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. J Am Coll Cardiol (2004) 1.75
Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am J Med Genet A (2005) 1.69
Determinants of cardiopulmonary functional improvement after transcatheter atrial septal defect closure in asymptomatic adults. J Am Coll Cardiol (2004) 1.68
Eisenmenger's syndrome and pregnancy. Obstet Gynecol Surv (1979) 1.67
Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet (2000) 1.62
Treatment of isolated secundum atrial septal defects: impact of age and defect morphology in 1,013 consecutive patients. Am Heart J (2008) 1.58
Subaortic stenosis in the spectrum of atrioventricular septal defects. Solutions may be complex and palliative. J Thorac Cardiovasc Surg (1995) 1.49
Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure. Circulation (2002) 1.46
Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation (1993) 1.45
Surgical treatment of adult atrial septal defect: early and long-term results. J Am Coll Cardiol (1992) 1.44
Isolated atrial septal defect with pulmonary vascular obstructive disease--long-term follow-up and prediction of outcome after surgical correction. Circulation (1987) 1.40
TBX5 genetic testing validates strict clinical criteria for Holt-Oram syndrome. Pediatr Res (2005) 1.38
Atrial septal defect in patients ages 60 years or older: operative results and long-term postoperative follow-up. Circulation (1981) 1.37
Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device: multicenter follow-up study. Pediatr Cardiol (2005) 1.33
Transcatheter closure of perimembranous ventricular septal defects: early and long-term results. J Am Coll Cardiol (2007) 1.32
Infective endocarditis in the grown-up congenital heart (GUCH) population. Eur Heart J (1998) 1.20
Long-term follow-up after surgical closure of ventricular septal defect in infancy and childhood. J Am Coll Cardiol (1994) 1.20
Surgical management of complete atrioventricular septal defects. A twenty-year experience. J Thorac Cardiovasc Surg (1995) 1.15
Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study. Int J Cardiol (2007) 1.13
Small ventricular septal defects in adults. Eur Heart J (1998) 1.09
Determinants of early and late results of repair of atrioventricular septal (canal) defects. J Thorac Cardiovasc Surg (1982) 1.04
2004 Canadian Cardiovascular Society Consensus Conference: Atrial Fibrillation. Can J Cardiol (2005) 1.00
Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder. Heart (1999) 0.98
Atrial septal defect in adults: cardiopulmonary exercise capacity before and 4 months and 10 years after defect closure. J Am Coll Cardiol (1997) 0.98
Outcome of patients after surgical closure of ventricular septal defect at young age: longitudinal follow-up of 22-34 years. Eur Heart J (2004) 0.98
Landmark article Feb 25, 1939: Surgical ligation of a patent ductus arteriosus. Report of first successful case. By Robert E. Gross and John P. Hubbard. JAMA (1984) 0.95
Maze procedure for atrial fibrillation associated with atrial septal defect. Circulation (1998) 0.94
INDICATIONS FOR REPAIR OF VENTRICULAR SEPTAL DEFECTS. Am J Cardiol (1963) 0.92
Assessment and follow-up of patients with ventricular septal defect and elevated pulmonary vascular resistance. Am J Cardiol (1989) 0.92
Surgery for partial atrioventricular septal defect in the adult. Ann Thorac Surg (1999) 0.91
Manifestations and results of treatment of patent ductus arteriosus in infancy and childhood; an analysis of 138 cases. Pediatrics (1955) 0.90
Secundum atrial septal defect with severe pulmonary hypertension. Open lung biopsy diagnosis of operative indication. Chest (1987) 0.89
Left atrioventricular valve incompetence after repair of common atrioventricular canal defects. Ann Thorac Surg (1995) 0.88
Predictors of atrial arrhythmias after device closure of secundum type atrial septal defects in adults. Am J Cardiol (2008) 0.88
Percutaneous catheter closure of the persistently patent ductus arteriosus in the adult. Am J Cardiol (1996) 0.88
The adult ductus: review of surgical experience with 131 patients. J Thorac Cardiovasc Surg (1981) 0.88
Orthodeoxia-platypnea due to intracardiac shunting--relief with transcatheter double umbrella closure. Cathet Cardiovasc Diagn (1995) 0.87
Long follow-up (to 43 years) of ventricular septal defect with audible aortic regurgitation. Am J Cardiol (1990) 0.85
Glenn Lecture. How to choose a cardiac surgeon. Circulation (1996) 0.84
[Persistent ductus arteriosus--is closure indicated also in asymptomatic adults with small ductus and minor shunt?]. Z Kardiol (1993) 0.83
Transcatheter occlusion of patent ductus arteriosus in adults. Am J Cardiol (1993) 0.83
Partial atrioventricular canal defect: long-term follow-up after initial repair in patients > or = 40 years old. J Am Coll Cardiol (1995) 0.82
Ventricular septal defect and aortic insufficiency. Surgical treatment. J Thorac Cardiovasc Surg (1977) 0.82
Prognostic factors and surgical treatment of partial atrioventricular canal. Circulation (1986) 0.82
Late results after repair of aortic insufficiency associated with ventricular septal defect. J Thorac Cardiovasc Surg (1992) 0.81
Selection of patients with secundum atrial septal defects for transcatheter device closure. Eur Heart J (2000) 0.81
Transfemoral closure of patent ductus arteriosus in adult patients. Int J Cardiol (1993) 0.80
Combined atrial septal defect surgical closure and irrigated radiofrequency ablation in adult patients. Ann Thorac Surg (2006) 0.79
Long-term follow-up after surgical repair of ostium primum atrial septal defects in adults. J Am Coll Cardiol (1996) 0.77
Comparison of hospital charges for closure of patent ductus arteriosus by surgery and by transcatheter coil occlusion. Am J Cardiol (1996) 0.76
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol (2002) 16.25
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Guidelines on the management of valvular heart disease (version 2012). Eur Heart J (2012) 10.70
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J (2007) 7.34
Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg (2012) 5.49
Outcomes in adults with bicuspid aortic valves. JAMA (2008) 2.94
Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation (2008) 2.93
Transcatheter device closure of atrial septal defects: a safety review. JACC Cardiovasc Interv (2013) 2.62
Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation (2008) 2.52
Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation (2006) 2.46
Projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low-flow, low-gradient aortic stenosis: the multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study. Circulation (2006) 2.29
Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study. Circulation (2006) 2.23
Comparison of the profiles of postoperative systemic hemodynamics and oxygen transport in neonates after the hybrid or the Norwood procedure: a pilot study. Circulation (2007) 2.16
Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J (2004) 2.11
Children and adults with congenital heart disease lost to follow-up: who and when? Circulation (2009) 2.10
Impact of transcatheter aortic valve implantation or surgical aortic valve replacement on right ventricular function. Heart (2012) 2.03
Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation (2004) 2.03
Impact of transcatheter aortic valve implantation or surgical aortic valve replacement on right ventricular function--the reply. Heart (2012) 1.98
Benefit of atrial septal defect closure in adults: impact of age. Eur Heart J (2010) 1.94
Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardiovasc Interv (2011) 1.94
Atrial arrhythmias in adults with congenital heart disease. Circulation (2009) 1.94
Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy. Am J Hum Genet (2013) 1.87
Univentricular heart. Circulation (2007) 1.85
Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J (2012) 1.82
Percutaneous tricuspid valve replacement in congenital and acquired heart disease. J Am Coll Cardiol (2011) 1.74
Determinants of outcome in isolated ventricular noncompaction in childhood. Am J Cardiol (2004) 1.67
Specialized adult congenital heart disease care: the impact of policy on mortality. Circulation (2014) 1.67
Late outcomes after pulmonary valve balloon dilatation in neonates, infants and children. J Invasive Cardiol (2005) 1.66
Adverse left ventricular mechanics in adults with repaired tetralogy of Fallot. Am J Cardiol (2008) 1.61
Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation (2004) 1.56
Escape capture bigeminy: phenotypic marker of cardiac sodium channel voltage sensor mutation R222Q. Heart Rhythm (2012) 1.53
[Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)]. G Ital Cardiol (Rome) (2013) 1.53
Vascular dysfunction after coarctation repair is related to the age at surgery. Int J Cardiol (2005) 1.53
Coarctation of the aorta and coronary artery disease: fact or fiction? Circulation (2012) 1.53
A biodegradable device (BioSTAR) for atrial septal defect closure in children. Catheter Cardiovasc Interv (2010) 1.52
Percutaneous coronary artery fistula closure in adults: technical and procedural aspects. Catheter Cardiovasc Interv (2007) 1.51
Gender differences in clinical presentation and surgical outcome of aortic stenosis. Heart (2010) 1.50
Systemic pressure does not directly affect pressure gradient and valve area estimates in aortic stenosis in vitro. Eur Heart J (2008) 1.49
Percutaneous closure of secundum atrial septal defect in adults a single center experience with the amplatzer septal occluder. J Invasive Cardiol (2003) 1.48
Cardiovascular disease and risk factors among 345 adults in rural India--the Andhra Pradesh Rural Health Initiative. Int J Cardiol (2006) 1.48
Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. Can J Cardiol (2011) 1.47
Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure. Circulation (2002) 1.46
Long-term outcome of patients with ventricular septal defect considered not to require surgical closure during childhood. J Am Coll Cardiol (2002) 1.46
Congenital heart defects in adulthood. Dtsch Arztebl Int (2011) 1.45
Infective endocarditis in children with congenital heart disease: cumulative incidence and predictors. Circulation (2013) 1.44
Starting a carotid artery stenting program is safe. Catheter Cardiovasc Interv (2008) 1.44
Intracardiac thrombus in adults with the Fontan circulation. Cardiol Young (2007) 1.42
The fellows stitch: large caliber venous hemostasis in pediatric practice. Catheter Cardiovasc Interv (2011) 1.42
Nocturnal breathing in cyanotic congenital heart disease. Int J Cardiol (2007) 1.41
Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndrome. Can J Cardiol (2010) 1.40
Transcatheter closure of patent foramen ovale with radiofrequency: acute and intermediate term results in 144 patients. Catheter Cardiovasc Interv (2009) 1.40
A diagnostic odyssey: detection of an unusual anterior papillary muscle of the tricuspid valve. Eur J Echocardiogr (2010) 1.39
Right ventricular end-diastolic wall stress: does it impact on right atrial size, and does it differ in right ventricular pressure vs volume loading conditions? Can J Cardiol (2012) 1.39
Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro. Circulation (2011) 1.38
Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J Am Coll Cardiol (2002) 1.36
Complications of pediatric cardiac catheterization: a review in the current era. Catheter Cardiovasc Interv (2008) 1.35
Left ventricular non-compaction: prevalence in congenital heart disease. Int J Cardiol (2012) 1.31
Repair of aortic false aneurysm using deep hypothermia and circulatory arrest. Ann Thorac Surg (2004) 1.31
Sudden cardiac death in adult congenital heart disease. Circulation (2012) 1.31
Cardiac masses: an integrative approach using echocardiography and other imaging modalities. Heart (2011) 1.29
B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol (2010) 1.26
B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study. Circulation (2007) 1.22
Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype. Circ Cardiovasc Genet (2011) 1.21
The impact of pulmonary valve replacement after tetralogy of Fallot repair: a matched comparison. Eur J Cardiothorac Surg (2007) 1.20
Transcatheter pulmonary valve implantation using the Edwards SAPIEN transcatheter heart valve. Catheter Cardiovasc Interv (2010) 1.15
Right heart assessment by echocardiography: gender and body size matters. J Am Soc Echocardiogr (2012) 1.14
Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol (2006) 1.13
Quantification of biventricular myocardial function using cardiac magnetic resonance feature tracking, endocardial border delineation and echocardiographic speckle tracking in patients with repaired tetralogy of Fallot and healthy controls. J Cardiovasc Magn Reson (2012) 1.13
Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol (2003) 1.13
Right ventricular-left ventricular interaction in adults with Tetralogy of Fallot: a combined cardiac magnetic resonance and echocardiographic speckle tracking study. Int J Cardiol (2010) 1.12
Predictors of outcomes in low-flow, low-gradient aortic stenosis: results of the multicenter TOPAS Study. Circulation (2008) 1.11
Cor Triatriatum Sinister diagnosed in adult life with three dimensional transesophageal echocardiography. BMC Cardiovasc Disord (2010) 1.11
The glycemic index and cardiovascular disease risk. Curr Atheroscler Rep (2007) 1.11
Diagnosis and management of pediatric myocarditis. Paediatr Drugs (2002) 1.10
A case of appropriate inappropriate device therapy: hyperkalemia-induced ventricular oversensing. Can J Cardiol (2008) 1.09
Interdigitating arch reconstruction eliminates recurrent coarctation after the Norwood procedure. J Thorac Cardiovasc Surg (2005) 1.09
Retrospective study to identify predictors of the presence and rapid progression of aortic dilatation in patients with bicuspid aortic valves. Nat Clin Pract Cardiovasc Med (2008) 1.08
Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study. Diabetes Care (2011) 1.08
Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary. Can J Cardiol (2010) 1.07